Get the Stockscreener App
34.97
1.01%
0.3485
Synaptogenix Inc stock is traded at $34.97, with a volume of 2,842.
It is up +1.01% in the last 24 hours and up +32.90% over the past month.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
See More
Previous Close:
$34.62
Open:
$34.85
24h Volume:
2,842
Relative Volume:
0.00
Market Cap:
$7.07M
Revenue:
-
Net Income/Loss:
$-8.22M
P/E Ratio:
-4.6963
EPS:
-7.4459
Net Cash Flow:
$-4.78M
1W Performance:
+4.23%
1M Performance:
+32.90%
6M Performance:
+613.64%
1Y Performance:
+959.65%
1-Day Range:
$34.56
$35.10
1-Week Range:
$33.81
$35.93
52-Week Range:
$1.84
$35.93
Synaptogenix Inc Stock (SNPX) Company Profile
Name
Synaptogenix Inc
Sector
Industry
Phone
(973) 242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare SNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNPX
Synaptogenix Inc
|
34.97 | 7.07M | 0 | -8.22M | -4.78M | -7.4459 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Synaptogenix Inc Stock (SNPX) Latest News
Latticework and mental models applied to investingTrading Volume Trends & Fast Growing Portfolio - bollywoodhelpline.com
What Wall Street predicts for Synaptogenix Inc. stock priceTechnical Analysis Insights & Ride the Wave of Market-Beating Growth - bollywoodhelpline.com
Popular Foundations Limited Stocks Attracting Dip BuyersMoving Average Strategies & Market Analysis Tools You Can Trust - bollywoodhelpline.com
Can Real Touch Finance Limited Bounce Back From Weekly LowMarket Volatility Update & Free Lightning Fast Capital Gains - bollywoodhelpline.com
Relief Rally in Agri Stock — Can It HoldMarket Volatility Update & High Profit Market Growth - Bollywood Helpline
Let me know your views in the comment section .High Frequency Trading Trends & Free Exceptional Risk Adjusted Gains - Bollywood Helpline
eFFECTOR Therapeutics (NASDAQ:EFTR) and Synaptogenix (NASDAQ:TAOX) Head to Head Review - Defense World
Will Introduced Innovation Sustain Hindoostan Mills Limiteds GrowthUtilities Sector Analysis & Small Investment Portfolio Tips - earlytimes.in
Hindalco Industries Limited Forms Double Bottom Pattern — Eyes on BreakoutStock Valuation Metrics & Superior Return Stocks - bollywoodhelpline.com
How Synaptogenix Inc. stock benefits from global expansionWeekly Trend Summary & Reliable Entry Point Alerts - Улправда
Is Synaptogenix Inc. stock a buy before product launches2025 Sector Review & Expert Verified Stock Movement Alerts - Улправда
Why analysts upgrade Synaptogenix Inc. stockJuly 2025 Setups & Weekly High Potential Alerts - DonanımHaber
Market Fear: Is Synaptogenix Inc. stock supported by innovation pipelineWeekly Trade Summary & Real-Time Stock Price Movement Reports - DonanımHaber
Why Synaptogenix Inc. stock could see breakout soonJuly 2025 Highlights & Daily Price Action Insights - DonanımHaber
Can Synaptogenix Inc. stock maintain operating marginsMarket Movement Recap & Weekly Return Optimization Plans - Улправда
What makes Synaptogenix Inc. stock attractive to growth fundsJuly 2025 Recap & High Yield Stock Recommendations - Улправда
Breakout Zone: Will Plutonian Acquisition Corp. Equity Warrant stock gain from government policiesWeekly Trade Review & Accurate Intraday Trading Signals - moha.gov.vn
Live Scanner Shows Breakout on Clean Science and Technology LimitedFundamental Stock Analysis & Achieve Consistent Profits - earlytimes.in
Value Recap: Does Synaptogenix Inc stock trade at a discount to peers2025 Earnings Surprises & Community Trade Idea Sharing - BỘ NỘI VỤ
How strong is Synaptogenix Inc. stock balance sheetTreasury Yields & Community Consensus Trade Signals - Newser
Will Synaptogenix Inc. stock reach all time highs in 2025Earnings Overview Report & Low Drawdown Trading Techniques - Newser
Does Synaptogenix Inc. stock trade at a discount to peersBreakout Watch & Capital Efficient Trade Techniques - Newser
Head to Head Comparison: Synaptogenix (NASDAQ:TAOX) versus Ceapro (OTCMKTS:CRPOF) - Defense World
Why hedge funds are buying Synaptogenix Inc. stockRisk Management & Weekly Setup with High ROI Potential - newser.com
Using R and stats models for Synaptogenix Inc. forecastingMarket Risk Report & Verified Short-Term Plans - newser.com
Is Synaptogenix Inc. stock a dividend growth opportunityM&A Rumor & Safe Entry Point Identification - newser.com
Will Synaptogenix Inc. stock outperform tech sector in 2025July 2025 Technicals & Fast Moving Stock Watchlists - newser.com
How rising interest rates impact Synaptogenix Inc. stockJobs Report & Accurate Technical Buy Alerts - newser.com
Why Synaptogenix Inc. is moving todayProduct Launch & High Win Rate Trade Alerts - newser.com
Is Synaptogenix Inc. stock a bargain at current levelsLayoff News & Smart Investment Allocation Insights - newser.com
How to build a dashboard for Synaptogenix Inc. stockJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
How moving averages guide Synaptogenix Inc. tradingJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Is GSPY stock ideal for retirement investorsJuly 2025 Retail & AI Enhanced Trading Signals - Fundação Cultural do Pará
TAO Synergies Bets Big On Decentralized AI Token Gains - Finimize
How to build a custom watchlist for Synaptogenix Inc.CPI Data & Accurate Technical Buy Alerts - newser.com
Synaptogenix Inc Stock (SNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):